In addition, an ERβ selective agonist, LY3201 inhibited NF-κB activation and neuroinflammation in murine models of demyelinating disorders, as did 5-androsten-3β, 17β-diol /ADIOL, another ERβ agonist (12, 111). Here, ESR2 is linked to demyelinating disease.